Iloperidone metabolite for use in the treatment of psychiatric disorders
US10874659B2 · kind B2 · utility
2Cited by
2References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 2013 |
| Grant date | Dec 29, 2020 |
| Priority date | — |
| Expiry date | Mar 14, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.